Table 6.
Correlation (r or ρ) between liver stiffness and studied parameters
|
LS |
|||
| HIV | HCV | HIV/HCV | |
| BMI | 0.11 | -0.1 | 0.02 |
| HCV genotype 3/non 3 | - | -0.1 | -0.26 |
| HCV-RNA | - | - | -0.26 |
| HIV-RNA | 0.21 | - | 0.18 |
| Time HAART | -0.047 | - | 0.09 |
| CD4 cells count | 0.074 | - | -0.32d |
| Alcohol | -0.096 | 0.70a | 0.30e |
| T-Chol | -0.09 | -0.32b | -0.18 |
| TG | 0.06 | 0.18 | 0.1 |
| HDL-Chol | -0.1 | 0.05 | -0.16 |
| Diabetes + IFG | -0.01 | 0.19 | 0.14 |
| Time HCV | - | 0.24 | -0.02 |
| ALT | 0.03 | 0.1 | 0.23 |
| AST | 0.18 | 0.56c | 0.40a |
| Platelets | -0.02 | -0.56c | -0.61c |
| APRI score | 0.04 | 0.70c | 0.50c |
| FIB-4 score | 0.06 | 0.75c | 0.60c |
LS: Liver stiffness; HIV: Human immunodeficiency virus; HCV: Hepatitis C virus; BMI: Body mass index; HAART: Highly active anti-retroviral therapy; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; T-Chol: Total cholesterol; HDL: High density lipoprotein; TG: Triglyceride; IFG: Impaired fasting glucose; APRI: Aminotransferase platelet ratio index.
a
P < 0.001;
b
P < 0.03;
c
P < 0.0001;
d
P < 0.02;
e
P < 0.04.